Contraceptive implants are small, flexible rods that are inserted under the skin of the woman’s upper arm. The implant is a highly effective long-acting reversible contraceptive (LARC) method that can play an essential role in meeting the large unmet need for family planning throughout the world.
In 2015, PSI inserted 287,994 implants, averting 405,652 disability-adjusted life years (DALYs) from distribution and 636,953 from insertion. This provided 960,515 couple years of protection (CYPs) and prevented 239,116 unintended pregnancies.
The one-rod implant, Implanon NXT, is effective for three years. Two-rod implants, Jadelle or Sino-Implant, are effective for five and four years, respectively. Insertion and removal require minimal equipment, making implants an attractive product offering for providers. Implants can be easily removed by a provider at any time, and women experience a fast return to fertility. Additionally, pelvic exams and vaginal contact are not required for implant insertion, increasing acceptability of the method among those consumers and providers whose discomfort with pelvic exams can be a barrier to use of other methods.
Implants are an essential part of our contraceptive method mix, increasing each consumer’s ability to find a method that best suits their needs, within the context of informed choice.
PSI markets contraceptive implants through social franchises in 23 countries. Working with private sector providers, we assure the quality of insertion and removal of contraceptive implants and informed choice among consumers. We also work with the public sector to provide contraceptive forecasting assistance, provider training and demand creation.
Making a Difference
In Mali, PSI launched an innovative urban outreach model to increase women’s access to long-acting reversible contraception (intrauterine devices and implants), within the context of informed choice.
Under a public-private partnership, PSI/Mali and the Ministry of Health created an outreach model to integrate voluntary family planning education and services with clinic immunization days. Trained midwives discuss LARC methods during group information sessions with women waiting for immunization services for their children and in one-on-one sessions with women who express an interest in a LARC method.
The model employs strong social marketing and behavior change communication to promote LARCs given that the methods are often unknown and underutilized. Trained midwives serve as dedicated LARC providers and travel from clinic to clinic to deliver services. Since 2008, PSI/Mali has provided more than 254,373 women with the LARC of their choice.
- Triggerise 2017 Annual Report
In October 2017, Triggerise developed a 3-year strategic plan, clearly articulating its vision, objectives and key results. By the end of 2020, Triggerise will have delivered cost efficient wealth and health impact to more than 1 million people. This annual report highlights the funding received from its largest donor – the Ministry of Foreign Affairs of the Netherlands, in partnership with PSI via project ignite – along with other new strategic donors investing in Triggerise’ development and impact.
- Ignite 2017 Annual Report
Project ignite looks further at the total market – informed by rigorous market assessments – and the various actors influencing the end user – to improve and correct underperforming aspects of the market and access to contraception and safe abortion services. This is the 2017 Annual Report that summarizes the key findings, successes, and lessons learned from PSI’s country operations in Haiti, Mozambique, and Cote d’Ivoire, as well as Triggerise’s innovations testing in India and Kenya.
- Ignite and Triggerise: 2017 Analytics and Insights
This report was shared at the ignite project meeting held in The Hague in October 2017, highlighting Triggerise’ progress to date with ignite and brand redesign activities following market research insights.
- Ignite and Triggerise: 2016 Annual Report
Triggerise’s 2016 Annual Report, sharing insights and results across all of its major donor-funded projects, including PSI/Dutch-funded project ignite.
- Ignite and PSI Mozambique’s TEM+ Escolas: Bringing Contraceptive Counseling and Product Delivery to Schools
In Mozambique, PSI’s network of Tem+ clinics are delivering contraceptive counseling and products directly to schools, challenging negative attitudes towards youth access to SRH services while simultaneously creating a positive enabling environment at the service delivery level.
- Adolescents 360: A Girl with a Plan!
Adolescents 360 aims to increase the demand for, uptake of and perception surrounding voluntary, modern contraceptives among adolescent girls in Nigeria, Tanzania and Ethiopia. This two-pager dives into the program’s unique Human-Centered Design approach to drive adolescent and youth sexual and reproductive health breakthrough.
- Ignite 2016 Annual Report
Project ignite looks further at the total market – informed by rigorous market assessments – and the various actors influencing the end user – to improve and correct underperforming aspects of the market and access to contraception and safe abortion services. This is the 2016 Annual Report that summarizes the key findings, successes, and lessons learned from PSI’s country operations in Haiti, Mozambique, and Democratic Republic of Congo, as well as Triggerise’s innovations testing in India and Kenya.
- Establishing a Sustainable Supply Chain for Young People in Haiti
OHMaSS has brokered a unique partnership with commercial distributor DISPROPHAR to incentive the private sector to take responsibility for the FP product category and drive it to scale. Meanwhile, providers are being trained by medical detailers to counsel young clients on contraceptive methods using a Closed Loop Marketing Tool, which strengthens DISPROPHAR’s sales force and helps the program monitor and improve providers’ engagement with their clients. This brief summarizes the key findings, successes, and lessons learned from ignite’s supply-side innovations in Haiti.
- Ignite: Sparking Innovation in Youth-Empowered Healthcare
Project ignite is testing two distinct market approaches as it seeks to break down barriers to access and use of voluntary, modern contraception among girls and young women (ages 15-24). This infographic visually showcases the complementary partnership between PSI and Triggerise.
- Women’s Limited Choice and Availability of Modern Contraception at Retail Outlets and Public-Sector Facilities in Luanda, Angola, 2012–2015
Despite high rates of unintended pregnancy, access to a wide range of contraceptive methods, especially injectables and long-acting reversible contraceptives (LARCs), is severely limited in both public and private facilities. Knowledge of contraceptive choices is likewise limited, yet a substantial proportion of women are not using their preferred method among the methods they know of.